Abstract
Respiratory syncytial virus (RSV) accounts for considerable morbidity among infants and elderly, that are otherwise immunocompetent. Immunocompromised haematological patients - in particular bone marrow transplant (BMT) recipients with leukopenia - are at high risk for severe, usually fatal, RSV-pneumonia. No randomized, placebo-controlled studies of aerosolized ribavirin for BMT patients with RSV-pneumonia have been conducted, or can be anticipated. We summarize existing case reports providing circumstantial evidence in favour of an active diagnostic and early therapeutic approach to these patients.
| Bidragets oversatte titel | Treatment of respiratory syncytial viral infections in immunocompromised haematological patients |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 162 |
| Udgave nummer | 35 |
| Sider (fra-til) | 4644-4647 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 28 aug. 2000 |
| Udgivet eksternt | Ja |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Behandling af respiratorisk syncytialvirus-infektioner hos immunkompromitterede hæmatologiske patienter'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS